title: Plasmapheresis reverses all side-effects of a cisplatin overdose--a case report and treatment recommendation.
abstract: BACKGROUND
  Cisplatin is widely used as an antineoplastic agent since it is effective against a broad spectrum of different tumours. Nevertheless, it has several potential side effects affecting different organ systems and an overdose may lead to life-threatening complications and even death.
  
  
  METHODS
  We report on a 46-year old woman with non-small cell lung cancer who accidentally received 225 mg/m2 of cisplatin, which was threefold the dose as scheduled, within a 3-day period. Two days later, the patient presented with hearing loss, severe nausea and vomiting, acute renal failure as well as elevated liver enzymes. In addition, she developed a severe myelodepression. After plasmapheresis on two consecutive days and vigorous supportive treatment, the toxicity-related symptoms improved and the patient recovered without any sequelae.
  
  
  CONCLUSIONS
  To date, no general accepted guidelines for the treatment of cisplatin overdoses are available. Along with the experience from other published cases, our report shows that plasmapheresis is capable of lowering cisplatin plasma and serum levels efficiently. Therefore, plasma exchange performed as soon as possible can ameliorate all side effects of a cisplatin overdose and be a potential tool for clinicians for treatment. However, additional intensive supportive treatment-modalities are necessary to control all occurring side effects.
authors.affiliation: Division of Oncology, Department of Internal Medicine, Medical University of Graz, Auenbruggerplatz 15, 8036 Graz, Austria. guenter.hofmann@meduni-graz.at
authors.forename: Guenter
authors.initials: G
authors.lastname: Hofmann
authors.forename: Thomas
authors.initials: T
authors.lastname: Bauernhofer
authors.forename: Peter
authors.initials: P
authors.lastname: Krippl
authors.forename: Doris
authors.initials: D
authors.lastname: Lang-Loidolt
authors.forename: Sabine
authors.initials: S
authors.lastname: Horn
authors.forename: Walter
authors.initials: W
authors.lastname: Goessler
authors.forename: Walter
authors.initials: W
authors.lastname: Schippinger
authors.forename: Ferdinand
authors.initials: F
authors.lastname: Ploner
authors.forename: Herbert
authors.initials: H
authors.lastname: Stoeger
authors.forename: Hellmut
authors.initials: H
authors.lastname: Samonigg
mesh_terms: D000970:Antineoplastic Agents / Q000097:blood / Q000633:toxicity*; D002289:Carcinoma, Non-Small-Cell Lung / Q000188:drug therapy; D002945:Cisplatin / Q000097:blood / Q000633:toxicity*; D005260:Female; D034381:Hearing Loss / Q000139:chemically induced; D006801:Humans; D008099:Liver / Q000201:enzymology; D008175:Lung Neoplasms / Q000188:drug therapy; D008875:Middle Aged; D009325:Nausea / Q000139:chemically induced; D010956:Plasmapheresis / Q000379:methods*; D051437:Renal Insufficiency / Q000139:chemically induced; D013997:Time Factors; D014839:Vomiting / Q000139:chemically induced
chemical_list: D000970:Antineoplastic Agents; D002945:Cisplatin